Changes in cerebrospinal fluid pressure after induction of anaesthesia with Althesin were recorded in 21 volunteer patients who had no abnormality of the central nervous or cardiorespiratory systems. In patients who breathed spontaneously, cerebrospinal fluid pressure fell by 45% at 1 min after intravenous injection of Althesin 0.1 ml/kg. It returned almost to preinduction levels by 12 min During this time, there was a slight increase in Pao 03 . When Paoo 2 was controlled by mechanical ventilation, the cerebrospinal fluid pressure fell slightly more; by 53% when Paoo, was kept between 38-42 mm Hg and by 50% when Pac 02 was maintained between 30-34 mm Hg. The significant fall of cerebrospinal fluid pressure produced by Althesin in conjunction with the rapid clear-headed recovery, may allow Althesin to be a valuable anaesthetic for neurosurgical procedures.
The control of cerebrospinal fluid pressure during general anaesthesia for neurosurgical operation is one of the most important items among the factors to be managed by anaesthetists. Of the inhalation anaesthetics in use at present, only nitrous oxide Is known not to increase cerebrospinal fluid pressure, and of the intravenous anaesthetics, only barbiturates are known to decrease cerebrospinal fluid pressure.
The new steroidal intravenous anaesthetic known as Althesin (CT1341) produces similar cardiorespiratory changes to the barbiturates (Campbell et al., 1971; Savege et al., 1972; Miller, Bradford and Campbell, 1972) whilst having a high therapeutic ratio, low local irritant effect and a rapid "clearheaded" recovery. In order to see whether this new agent could be considered for use in neurosurgery, we have studied its effects on cerebrospinal fluid pressure (c.s.f.p.).
METHOD

Subjects.
Twenty-one patients awaiting surgery, with no disorders of the central nervous system, respiratory or cardiovascular systems, served as volunteers for this experiment. They were divided into three groups of 7 as follows: Group 1, spontaneous respiration; Group 2, mechanically ventilated to maintain Paoo, between 38 and 42 mm Hg; Group 3, mechanically ventilated, Paco 3 maintained between 30 and 34 mm Hg.
The sex, age and weight of the volunteers in each group were as shown in table I. 
Anaesthesia.
No premedication was given to any of the volunteers. In order to ensure the intravenous infusion route, 300-500 ml lactate-Ringer solution was ad-ministered by drip before commencing the study, and the flow rate was reduced to a minimum 10 min before and during the measurement of cerebrospinal fluid pressure. Oxygen 1-2 l./min was given via a facepiece to 5 of the 7 volunteers in group 1, the remaining 2 received none.
In patients of groups 2 and 3, anaesthesia was induced with nitrous oxide 7 l./min and oxygen 2 l./min and endotrachel intubation was performed after intravenous injection of tubocurarine 30 mg. The tube was connected to a Bird Mark IV, 8 ventilator for controlled ventilation. Together with additional tubocurarine, anaesthesia was maintained with nitrous oxide 5-6 l./min and oxygen 2 l./min and cerebrospinal fluid pressure was monitored. Total tubocurarine administered before commencement of the study was 60-75 mg.
Adjustment of arterial carbon dioxide tension.
The ventilation volume was regulated to maintain arterial carbon dioxide tension (Pao O j) in groups 2 and 3 within the pre-set range. Arterial blood was drawn through an indwelling cannula in the radial artery, heparinized and excluded from air. Blood-gas was analysed by the Astrup method. Studies were carried out after the blood gas reading had remained constant for at least 15 min. In both group 2 and group 3, arterial oxygen tension (Pao 3 ) was maintained between 90 and 130 mm Hg. Blood-gas values were monitored at the end of the study and several times when significant changes in cerebrospinal fluid pressure occurred. Only the data from patients in whom Pao 2 and Pa<,oj were within the above mentioned limits have been included.
Monitoring and recording.
With the subject lying in the lateral position, arterial pressure, central venous pressure and cerebrospinal fluid pressure were recorded throughout the study. Arterial and central venous pressures were monitored using catheters introduced percutaneously into the radial artery, and superior caval vein via a cubital fossa vein, respectively. The position of the tip of the central venous catheter was confirmed by the length of the catheter inserted, and also by observation of the pressure curve on the monitoring recorder. For measurements of cerebrospinal fluid pressure, a no. 21 needle was introduced into the space between the third and fourth lumbar vertebrae. A tube was attached, and connected to a recorder (Nihon Koden RM150) together with the two other catheters via transducers (transducer MPU0.5 for arterial pressure and LPU0.1 for central venous pressure). Continuous measurements were performed at least 20 min before and 12 min after the administration of Althesin.
The top of the manubrium sterni was taken as zero level for central venous and arterial pressures. The cisterna magna and the point of the lumbar needle were placed at the same level and taken as zero level for cerebrospinal fluid pressure.
With patients in group 1, arterial blood was drawn and measurements of Paoj, Pa C oj and arterial blood pH were obtained at 1.5, 3, 5, 7, 10 and 12 min respectively after administration of Althesin.
Dose and method of administration.
Althesin 0.1 ml/kg was administered intravenously over an injection time of 30 sec in all three groups.
RESULTS
The changes in cerebrospinal fluid, arterial and central venous pressures for each group are shown in table II. Examples thereof are given in figures 1 and 2.
Cerebrospinal fluid pressure.
This fell in all 21 patients. Mean maximum falls were 45% in group 1, 53% in group 2 and 50% in group 3, these being statistically significant. In group 1 the maximum fall occurred 1 min after injection, the pressure then rising gradually to approach the control value at 12 min. In groups 2 and 3, the pressure fell rapidly after administration of Althesin, and continued to fall gradually to reach the minimum value at 5-8 min after induction. It later rose slightly but was still significantly below the mean control level at 12 min.
Arterial pressure.
Mean arterial pressure fell in all cases. The mean maximum falls were 27% in group 1, 24% in group 2 and 18% in group 3 and these falls achieve statistical significance (P<0.01). The maximum falls of blood pressure were reached at 1 min after induction in many patients while in others, after a slight and temporary recovery, they were reached 10 min after administration. The mean level was still below preanaesthetic levels 12 min after induction in all but 2 patients (see table II).
Central venous pressure.
Central venous pressure fell T)y a mean of 54% in group 1, 57% in group 2 and 44% in group 3. cv.p.
B.P.
•.V.'.'.W CS.F.P. It fell immediately after intravenous induction, and often remained at that level. In these three groups the mean falls below mean initial values reached significance.
Arterial blood-gas analysis. Changes in Pao, and Pao Oj in group 1, as obtained from arterial blood-gas analysis, are shown in figure  3 . With the exception of 1 case, Pao, tended to fall temporarily after injection of Althesin. In the most marked 2 cases breathing air, oxygen tension felTby 14 mm Hg and 22 mm Hg 1.5 min after administration. Pa O o 3 tended to rise 3 min after injection, and showed an average increase of 2.7 mm Hg 7 min after administration. pH was maintained within the normal range in all cases. 
DISCUSSION
Discussion of study conditions.
The factor which has the most marked effect on cerebrospinal fluid pressure is the change in cerebral blood flow caused by changes of Paoo,. The graph of the relation between Paoo 3 and cerebral blood flow is a sigmoid curve; a slight rise in Paco 3 causes a significant increase in cerebral blood flow, and similarly a fall in Paco 3 causing a decrease. A change in cerebral blood flow is immediately reflected in changes of cerebrospinal fluid pressure. In the group breathing spontaneously, observation of Pao 0 j at regular intervals showed slight increases and this agrees with Campbell and associates (1971) and Savege and associates (1971) who have also reported a rise in Pa^ of 2-3 mm Hg. The fall of cerebrospinal fluid pressure in group 1 evidently overrides the tendency of an elevated Paooi to increase it. Reivich (1964) has stated that Pa<j a between 60 mm Hg and 380 mm Hg does not affect cerebral blood flow. After administration of Althesin, mean Pao, falls by about 18 mm Hg according to Campbell and associates (1971) and up to 13 mm Hg according to Savege and associates (1971) . In our patients breathing spontaneously there was a decrease in Pao 2 , but it was possible to mninmin Pa^ at 85-180 mm Hg by inhalation of low concentrations of oxygen. Arterial blood pH was also within the normal limits, and it may be said that the effect of these two factors on cerebral blood flow and cerebrospinal fluid pressure is but slight. Data from subjects in group 2 (Paooj 38-42 mm Hg) in whom the Paoj was below 90 and above 130 mm Hg were discarded. This was done in order to exclude the effects of changes of blood gases, especially of Paco^j on cerebrospinal fluid pressure. The fact that the conditions of this study laid down in group 2 do not affect cerebrospinal fluid pressure has been reported previously by Takasaki (1972) . After elimination of the effects brought about by changes in blood-gas content cerebrospinal fluid pressure was observed to diminish by a mean of 53%, an 8% larger fall than that observed in group 1. In group 1, the minimum level was recorded 1 min after administration but in group 2, however, the fall continued and reached the minimum level at 5-8 min after administration. The fall was still significant at 12 min after Althesin injection.
In neurosurgical anaesthesia, hyperventilation is often used in an attempt to decrease cerebral blood flow by reducing Paco 2 and thus decreasing cerebrospinal fluid pressures. Results in group 3 show that the additional hyperventilation in this group did not produce falls significantly greater than those of group 2. The duration of the pressure fall was identical to that of group 2. Thus, clearly, Althesin significantly decreases cerebrospinal fluid pressure in both normocapnic and hypocapnic subjects and maintains this low level for quite some time, at least until recovery from anaesthesia.
Comparison with other anaesthetics.
The only intravenous anaesthetics now in use which lower cerebrospinal fluid pressures are barbiturates. It is known that, if respiratory depression is prevented, barbiturates will significantly decrease the pressure (Horsley, 1937; Stephen et aL, 1954; S0ndergard, 1961) and also the cerebral blood flow (Pierce, et al., 1962; McDowall, 1965) by reducing cerebral oxygen uptake. In view of these properties, barbiturates have been the anaesthetic agent employed in neurosurgical operations, despite their relatively marked depression of respiratory and circulatory systems and also retardation of recovery. Althesin also caused a fall in blood pressure but there was an increase in pulse rate and it has been found to cause no change in (Campbell et al., 1971) or a tendency to increase (Savege et al., 1971 ) cardiac output. As regards respiration, transient respiratory depression or apnoea of about 30-sec duration may occur after intravenous injection of Althesin which is followed by an increase in respiratory rate, and the rise in Paooa is not substantial. Pao-is clearly observed to fall but this can be prevented by a small increment of oxygen in the inhaled air. Comparing our data concerning the effect of barbiturates on cerebrospinal fluid pressure, which are not yet complete, we believe that Althesin causes the pressure to decrease as much as, or more than, do barbiturates. Althesin appears likely to bring about the greatest fall in cerebrospinal fluid pressure among anaesthetic agents in common use.
Discussion of a possible mechanism of fall in
cerebrospinal fluid pressure. Both arterial pressure and Paoo, affect cerebrospinal fluid pressure but, generally speaking, when there is a gradual rise or fall in arterial pressure, there is no change in pressure because cerebral blood flow is kept constant by the homeostatic mechanism of the cerebral circulation. However, this compensatory mechanism is thought not to be proof against sudden changes (Harper, 1969) . Furthermore, in our study central venous pressure fell concomitantly with the arterial pressure after administration of Althesin and this could have been sufficient to override the homeostatic mechanism and to reduce cerebrospinal fluid pressure. Under the experimental conditions described it was not possible for changes in blood-gases to modify cerebrospinal fluid pressure, or for cerebral mass volume or cerebrospinal fluid volume to change suddenly following administration of the drug (McDowall, 1969) .
Whether Althesin directly affects cerebral blood vessels or indirectly reduces brain circulation by changing the distribution of blood or diminishes cerebral oxygen requirements has yet to be clarified. Considering that Althesin causes peripheral vasodilatation (Du Cailar, 1972) , and cerebral vasoconstrictive changes are known to be related mainly to blood-gas levels, it is rather unlikely that Althesin would directly impede the brain circulation. In view of the significant fall in cerebrospinal fluid pressure, it may be surmised that some additional factors other than fall in arterial pressure and central venous pressure may be acting here. 
SOMMAIRE
RESUMEN
Fueron registrados los cambios en la presi6n de Iiquido cefalorraquideo despues de la induction de anestesia con Althesin en veintiiin patiences voluntarios que presentaban anormalidad del sistema nervioso central o cardiorrespiratorio. En pacientes que respiraban espontaneamente la presi6n del Iiquido cefalorraqufdeo descendi6 en un 45 por ciento un minuto despues de la inyecci6n intravenosa de 0,1 ml/kg de Althesin. A los 12 minutos habia vuelto casi a los niveles anteriores a la inducci6n. Durante este itempo hubo un ligero incremento de la Paco,. Cuando fue controlada la Paco, mediante respiraci6n mecanica hubo un descenso ligeramente mayor de la presidn del Iiquido cefalorraqufdeo: Un 53 por ciento cuando la Paco, fue mantenida entre 38-42 mm Hg y un 50 por ciento cuando la Paco, fue mantenida entre 30-34 mm Hg. El descenso significativo de la presi6n del lfquido cefalorraquideo producido por Althesin y la rapida recuperation con pensamiento daro pueden permitir que Ahhesin sea un anestisico valioso para las intervenciones neuroquinirgicas.
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